Robert (‘Bob’) Watson is the President and CEO of Juvare, LLC (formerly Intermedix), the worldwide leader in incident command and emergency preparedness technology. Bob joined Juvare with more than 35 years’ experience leading multiple technology and SaaS-based companies. His vision is to strengthen and optimize information sharing to empower preparedness and response professionals to protect people, property, and brands.
In addition to leading Juvare, Bob is a Director of Cel-Sci Corporation, Vienna, and VA (NYSE:CVM} where he is Chairman of the Compensation Committee. Throughout his career, Bob has participated in over 75 acquisitions, raised nearly $1 Billion in capital, completed three public offerings and successfully sold four companies.
Prior to Juvare, Bob was the President of NantHealth (NASDAQ: NH) from January 2015 to May 2017. He was also the CEO and President, as well as a Director of Streamline Health (NASDAQ: STRM) from January 2011 to January 2015. Bob formerly served as Chairman of Orthus Health (Raleigh, NC) from June 2016 until November 2017and as a Director of Oncology Business Solutions (Albuquerque, NM) from May 2015 until May 2017.
Bob obtained his MBA in Healthcare Administration and Finance from The Wharton School of Business at the University of Pennsylvania. He received a Bachelor of Science from Syracuse University in Health Policy Studies and Information and Library Science.
Bob is an avid runner, a horrible but enthusiastic golfer and an enthusiastic fan of all things Syracuse University.